|
|
|
|
first-line osimertinib in patients with treatment-naive somatic or germline egfr t790m–mutant metastatic nsclc
|
|
|
|
|
|
|
|
نویسنده
|
ancevski hunter k. ,friedland d.m. ,villaruz l.c. ,burns t.f.
|
|
منبع
|
journal of thoracic oncology - 2018 - دوره : 13 - شماره : 1 - صفحه:e3 -e5
|
|
|
|
|
|
|
|
آدرس
|
university of pittsburgh medical center, usa, university of pittsburgh medical center, usa, university of pittsburgh medical center, usa, university of pittsburgh medical center, usa
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|